NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 133 filers reported holding NEOGENOMICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,012,000 | +150.5% | 128,300 | +160.8% | 0.06% | +93.9% |
| Q3 2016 | $404,000 | +22.8% | 49,200 | -38.1% | 0.03% | -40.0% |
| Q4 2014 | $329,000 | -1.5% | 79,500 | +23.1% | 0.06% | +10.0% |
| Q3 2014 | $334,000 | +76.7% | 64,600 | +13.7% | 0.05% | +78.6% |
| Q2 2014 | $189,000 | -3.6% | 56,800 | 0.0% | 0.03% | -6.7% |
| Q1 2014 | $196,000 | – | 56,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |